sharetrader
Results 1 to 10 of 77

Threaded View

  1. #11
    On the doghouse
    Join Date
    Jun 2004
    Location
    , , New Zealand.
    Posts
    9,335

    Default Buffett Growth Model (2018 Perspective): Data

    Quote Originally Posted by Snoopy View Post
    The objective of the Buffett growth model is to sum the gains of dividends and capital appreciation over an extended period, and calculate a compounding rate of annual return taking into account all tax liabilities incurred on the way.

    The Buffett growth model operates by:

    1/ Starting with shareholder equity at the start of Year 1,
    2/ Working out a projected return on this equity using an averaged return on this equity from previous years.
    3/ Apportioning this return between dividends, share buybacks and what remains to be reinvested within the company. New Capital raised outside of normal operations during the year must be taken into account.
    4/ Recycling any retained earnings into subsequent year shareholder equity. Then using this new Shareholder equity total as the earnings base for the subsequent year. The subsequent year becomes the new starting point for this process to repeat.

    YUMC is an 'overseas share', caught by NZ's FIF tax regime. FIF tax is paid on 5% of the opening balance of each share owned. At a tax rate of 30%, this works out at:

    0.3 x 0.05 = 0.015, or 1.5% of the opening balance total, payable each year (actually FIF tax is charged on a whole of portfolio basis. But for the purpose of this exercise, we shall assume the entire FIF portfolio consists of YUMC shares only) For NZers, this FIF tax has to be separately accounted for in this calculation each year, and summed over the study period

    We are looking at a study period, ten years into the future. The amount that must be paid for this FIF tax can be netted off against any overseas withholding tax paid on dividends. That is because, under the FIF regime, there is no separate tax on dividends. The withholding tax on dividends on NYSE listed YUMC and paid by YUMC on the investor's behalf is currently 15%.

    Return On Shareholder Equity: Working Figure

    Post 21 allows us to calculate an averaged five year ROE figure:

    ( 13.1% + 18.8% + 19.4% + 20.7% + 21.9 %) / 5 = 18.8%

    Price Earnings Ratio: Working Figure

    To value our share each year, we need to calculate an appropriate PE value to use. Despite operating for some thirty years, YUMC has only been separately listed for three. Using just three data points is not a very reliable way to calculate a representative average PE figure. This is particularly so when one of those figures was inflated by a since withdrawn takeover offer (Year 2017). I have taken 15% off the year 2017 PE figure to remove this takeover premium.

    ( 21.4 + 0.85x27.2 + 25.2 ) /3 = 23.2

    The derivation of this PE figure has been calculated using a shallow data set. Nevertheless it is the best figure we can get, based on the possibly not representative three year sharemarket trading period we have to draw information from.

    Dividends

    Only one dividend of 10c per share has been declared over FY2017, the latest year in which an annual report was published. This relates to the period Q4 for FY2017. Over FY2018 there have been four quarterly dividends declared: 10cps, 10cps, 10cps and 12 cps. Given the growth path of the company, I am forecasting dividends for FY2021 to be 13cps, 13cps, 13cps and 13cps. Following an incremental pattern, I am going to model future dividend payments for the years in which we are studying to be as follows:

    Forecast Dividend
    FY2018 42cps
    FY2019 42cps
    FY2020 46cps
    FY2021 52cps
    FY2022 58cps
    FY2023 64cps
    FY2024 70cps
    FY2025 76cps
    FY2026 82cps
    FY2027 88cps
    FY2028 94cps

    Share Buybacks

    On 4th October 2017, the board increased the aggregate quantum of shares to be repurchased to $550m. As of the end of FY2018, the aggregate of share repurchases had reached $455m. That leaves $95m worth of shares still authorized to be bought back. Yet counter intuitively, the number of shares on issue continues to go up year on year. What is the explanation for this?

    As stated in AR2017 p37:

    "The company's executive compensation program has three primary pay components: base salary, annual performance based cash bonuses and long term equity awards."

    We learn on p119 of AR2017 that:

    "The company has reserved for issuance under the "Yum China Holdings Inc. Long Term Incentive Plan" 45 million shares of our common stock. Under this plan, the excise price of stock options and SARs (Stock Appreciation Rights) granted must be equal to or greater than the fair market value of the company's stock on the date of the grant"

    Options and SARs vest after three to five years and expire ten years after they were granted. Share based compensation is recognized in the "Consolidated and Combined Financial Statements" on a straight line basis over the service period based on their fair value on the date of the grant. When the options are redeemed, the company gets a cash injection based on the awarded price of the share options granted. But the employee gets to keep the difference between the price at the time the option was awarded and today's market price.

    Again from p121 of AR2017, at the end of that year, 14.072m shares become exercisable at a weighted average excise price of $16.69. If all of these were exercised, this would represent a capital inflow to shareholders equity of:

    14.072m x $16.69 = $235m

    Actual new equity inflow over the period was $27m. That is equivalent to about 1.617m new ordinary shares created ( $16.69 x 1.617m = $27m)

    The current authorized buy back limit of $95m would buy back 2.375m shares at $40 each. 2.375m shares to be redeemed is way short of the new 14.072m -1.617m = 12,455m shares that could be created at any time. it looks like the number of shares bought back will continue to be outweighed by the number of employee earned new shares vesting.
    The objective of the Buffett growth model is to sum the gains of dividends and capital appreciation over an extended period, and calculate a compounding rate of annual return taking into account all tax liabilities incurred on the way.

    The Buffett growth model operates by:

    1/ Starting with shareholder equity at the start of Year 1,
    2/ Working out a projected return on this equity using an averaged return on this equity from previous years.
    3/ Apportioning this return between dividends, share buybacks and what remains to be reinvested within the company. New Capital raised outside of normal operations during the year must be taken into account.
    4/ Recycling any retained earnings into subsequent year shareholder equity. Then using this new Shareholder equity total as the earnings base for the subsequent year. The subsequent year becomes the new starting point for this process to repeat.

    YUMC is an 'overseas share', caught by NZ's FIF tax regime. FIF tax is paid on 5% of the opening balance of each share owned. At a tax rate of 30%, this works out at:

    0.3 x 0.05 = 0.015, or 1.5% of the opening balance total, payable each year (actually FIF tax is charged on a whole of portfolio basis. But for the purpose of this exercise, we shall assume the entire FIF portfolio consists of YUMC shares only) For NZers, this FIF tax has to be separately accounted for in this calculation each year, and summed over the study period

    We are looking at a study period, ten years into the future. The amount that must be paid for this FIF tax can be netted off against any overseas withholding tax paid on dividends. That is because, under the FIF regime, there is no separate tax on dividends. The withholding tax on dividends on NYSE listed YUMC and paid by YUMC on the investor's behalf is currently 15%.

    Return On Shareholder Equity: Working Figure

    Post 35 allows us to calculate an averaged five year ROE figure:

    ( 12.9% + 18.6% + 19.3% + 20.6% + 21.3% ) / 5 = 18.5%

    Price Earnings Ratio: Working Figure

    To value our share each year, we need to calculate an appropriate PE value to use. Despite operating for some thirty years, YUMC has only been separately listed for three. Using just three data points is not a very reliable way to calculate a representative average PE figure. This is particularly so when one of those figures was inflated by a since withdrawn takeover offer (Year 2017). I have taken 15% off the year 2017 PE figure to remove this takeover premium.

    ( 22.1 + 0.85x27.5 + 27.7 ) /3 = 24.4

    The derivation of this PE figure has been calculated using a shallow data set. Nevertheless it is the best figure we can get, based on the possibly not representative three year sharemarket trading period we have to draw information from.

    Dividends

    Over FY2018 there have been four quarterly dividends declared: 10cps, 10cps, 10cps and 12 cps. The first half of FY2019 has seen two dividends of 12cps being declared, an annualized rate of 48cps. Given the growth path of the company, I am forecasting dividends for FY2021 to be 13cps, 13cps, 13cps and 13cps. Following an incremental pattern, I am going to model future dividend payments for the years in which we are studying to be as follows:

    Forecast Dividend
    FY2018 (actual) 42cps
    FY2019 48cps
    FY2020 48cps
    FY2021 52cps
    FY2022 58cps
    FY2023 64cps
    FY2024 70cps
    FY2025 76cps
    FY2026 82cps
    FY2027 88cps
    FY2028 94cps

    Share Buybacks

    On 4th October 2017, the board increased the aggregate quantum of shares to be repurchased to $550m. As of the end of FY2018, the aggregate of share repurchases had reached $455m. That leaves $95m worth of shares still authorized to be bought back. Yet counter intuitively, the number of shares on issue continues to go up year on year. What is the explanation for this?

    As stated in AR2018 p40:

    "The company's executive compensation program consists of three primary pay components: (i) base salary, (ii) annual performance based cash bonuses or short term incentives and (iii) long term equity awards."

    We learn on p121 of AR2018 that:

    "Effective 31st October 2016, the company has reserved for issuance under the "Yum China Holdings Inc. Long Term Incentive Plan" 45 million shares of our common stock. Under this plan, the excise price of stock options and SARs (Stock Appreciation Rights) granted must be equal to or greater than the fair market value of the company's stock on the date of the grant"

    Over the remainder of FY2016, 25.274m of these long term incentive plan rewards were issued as part of the demerger process, 0.5m more were granted and 0.456m were forfeited or expired (AR2016 p115). So by the end of FY2016 the net plan shares issued were:

    25.274m + 0.500m - 0.456m = 25.318m

    We can record the change in rights issued in subsequent years as follows:

    Employee Options Authorised Remaining
    Total (start of period) less Options Granted during year add Options Cancelled during year equals Remaining Options to be Authorised (end of period)
    At 31st October 2016 45m (25.274m) 19.726m
    FY2016 19.726m (0.500m) 0.456m 19,682m
    FY2017 19.682m (2.234m) 1.199m 18.647m
    FY2018 18.647m (1.179m) 0.611m 18.079m

    In 'number of option' terms, this means there are plenty still available to be issued.

    Options and SARs vest after three to five years and expire ten years after they were granted. Share based compensation is recognized in the "Consolidated and Combined Financial Statements" on a straight line basis over the service period based on their fair value on the date of the grant. When the options are redeemed, the company gets a cash injection based on the awarded price of the share options granted. But the employee gets to keep the difference between the price at the time the option was awarded and today's market price.

    Again from p123 of AR2018, at the end of that year, 12.407m shares become exercisable at a weighted average excise price of $18.64. If all of these were exercised, this would represent a capital inflow to shareholders equity of:

    12.407m x $18.64 = $231m

    Actual new equity inflow over the FY2018 period from share based compensation was $24m (AR2018 p91). That is equivalent to 3m new ordinary shares created (AR2018 p91).

    During FY2018 (AR2018 p124), the company repurchased 9.0m shares during FY2018 (total cost $312m) and $960m remains available for purchase under current authorization. This remaining to purchase balance is up from the $422m available for future purchases a year earlier (AR2017 p122). So there doesn't seem to be any problem increasing the buy back authorization if management see fit to do so.

    $960m would buy back 24m shares at $40 each. 24m shares exceeds the employee compensation package new equity that could now be created at any time.

    12.407m shares x $18.64 per share = $231m (Potential employee new equity contribution EOFY2018)

    So now the number of shares that could be bought back outweigh the number of employee earned new shares that could be redeemed.

    Nevertheless warrant agreements with two strategic investors (AR2018 p115) could see 7.309m plus 0.891m = 8.2m new shares issued before October 31st 2021. Since these warrants are well 'in the money' I expect this will happen in due course. So I don't see the number of shares in YUMC decreasing over the next few years, despite the on market share buybacks.

    SNOOPY
    Last edited by Snoopy; 10-02-2021 at 11:59 AM.
    Watch out for the most persistent and dangerous version of Covid-19: B.S.24/7

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •